Magdalena Matuszak

Poznan, WP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Haematology

Published: November 21, 2025

Introducing CAR T-cell therapy into clinical practice for mantle cell lymphoma: real-world experience from Poland.

Introducing CAR T-cell therapy into clinical practice for mantle cell lymphoma: real-world experience from Poland.

Journal: Archives of medical science : AMS

Published: October 29, 2025

CD34+/CD3+ cells ratio in the peripheral blood stem cells product and graft-versus-host disease: Is there still room for improvement?

CD34+/CD3+ cells ratio in the peripheral blood stem cells product and graft-versus-host disease: Is there still room for improvement?

Journal: Transplant immunology

Published: October 03, 2025

Should we Cryopreserve Allogenic Hematopoietic Stem Cell Grafts?

Should we Cryopreserve Allogenic Hematopoietic Stem Cell Grafts?

Journal: In vivo (Athens, Greece)

Published: November 12, 2024

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Journal: Polish archives of internal medicine

Published: May 15, 2024

Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Journal: Blood

Published: February 13, 2024

Parameter Identification of the Fractional-Order Mathematical Model for Convective Mass Transfer in a Porous Medium.

Parameter Identification of the Fractional-Order Mathematical Model for Convective Mass Transfer in a Porous Medium.

Journal: Membranes

Published: August 21, 2023

Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.

Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.

Journal: British journal of haematology

Published: June 28, 2023

Microscopic Droplet Size Analysis (MDSA) of "Five Thieves' Oil" (Olejek Pięciu Złodziei) Essential Oil after the Nebulization Process.

Microscopic Droplet Size Analysis (MDSA) of "Five Thieves' Oil" (Olejek Pięciu Złodziei) Essential Oil after the Nebulization Process.

Journal: Molecules (Basel, Switzerland)

Published: April 18, 2023

Second allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia: a retrospective single-center analysis of the outcome.

Second allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia: a retrospective single-center analysis of the outcome.

Journal: Polish archives of internal medicine

Published: February 21, 2023

Monitoring of Measuring Devices Using a Programmable Logic Controller and a Dedicated Desktop Application.

Monitoring of Measuring Devices Using a Programmable Logic Controller and a Dedicated Desktop Application.

Journal: Sensors (Basel, Switzerland)

Published: October 15, 2022

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: August 05, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026